{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:51:41Z","timestamp":1697291501364},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.biologicals.2007.02.001","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T11:10:16Z","timestamp":1175598616000},"page":"142-143","source":"Crossref","is-referenced-by-count":6,"title":["Selection of spiking materials for studies on the clearance of agents of transmissible spongiform encephalopathy during plasma fractionation"],"prefix":"10.1016","volume":"36","author":[{"given":"Peter R.","family":"Foster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2007.02.001_bib1","series-title":"CHMP position statement on Creutzfeldt\u2013Jakob disease and plasma-derived and urine-derived medicinal products","author":"Committee for Medicinal Products for Human Use","year":"2004"},{"key":"10.1016\/j.biologicals.2007.02.001_bib2","series-title":"Guideline on the investigation of manufacturing processes for plasma-derived medicinal products with regard to vCJD risk","author":"Committee for Medicinal Products for Human Use","year":"2004"},{"issue":"Suppl. 2","key":"10.1016\/j.biologicals.2007.02.001_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1741-6892.2004.00444.x","article-title":"Removal of TSE agents from blood products","volume":"87","author":"Foster","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2007.02.001_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/biol.2002.0327","article-title":"Purity of spiking agent affects partitioning of prions in plasma protein purification","volume":"30","author":"Vey","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2007.02.001_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1537-2995.2006.00763.x","article-title":"Preparation of\u00a0soluble infectious samples from scrapie-infected brain: a new tool to study clearance of transmissible spongiform encephalopathy agents during plasma fractionation","volume":"46","author":"Berardi","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2007.02.001_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biologicals.2005.11.007","article-title":"CJD PrPSC removal by nanofiltration process: application to a therapeutic imunoglobulin solution (Lymphoglobuline\u00ae)","volume":"34","author":"Truchot","year":"2006","journal-title":"Biologicals"},{"issue":"Suppl. 4","key":"10.1016\/j.biologicals.2007.02.001_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2516.2004.00982.x","article-title":"Variant Creutzfeldt\u2013Jakob disease: risk of transmission by blood and blood products","volume":"10","author":"Ironside","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2007.02.001_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.copbio.2005.07.006","article-title":"The clearance of\u00a0viruses and transmissible spongiform encephalopathy agents from biologicals","volume":"16","author":"Farshid","year":"2005","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.biologicals.2007.02.001_bib9","author":"Health Protection Agency"},{"key":"10.1016\/j.biologicals.2007.02.001_bib10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tmrv.2006.03.007","article-title":"An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt\u2013Jakob disease","volume":"20","author":"Cervia","year":"2006","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2007.02.001_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1537-2995.2006.00865.x","article-title":"Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion affinity ligands","volume":"46","author":"Gregori","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2007.02.001_bib12","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(06)69897-8","article-title":"Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins","volume":"368","author":"Gregori","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2007.02.001_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1423-0410.2002.00211.x","article-title":"Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin","volume":"83","author":"Reichl","year":"2002","journal-title":"Vox Sang"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105607000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105607000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T11:52:14Z","timestamp":1546948334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105607000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1045105607000413"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2007.02.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}